Fibromyalgia is one of those conditions that can be hard to explain to anyone who has not lived with it. Widespread pain, broken sleep and mental fog often arrive together and stay for years, which is why so many people keep researching new options long after the usual ones have been tried.
This article looks at what fibromyalgia actually involves, what published research has explored around pressurised oxygen environments, the explanations scientists have put forward for their findings and why the fine print of each study protocol matters when you are reading about results.
What Fibromyalgia Actually Involves
Fibromyalgia is characterised by chronic widespread pain that lasts for months or longer, usually alongside fatigue, unrefreshing sleep and difficulty with concentration or memory. Estimates suggest it affects somewhere between two and four percent of adults worldwide, and it is diagnosed more often in women than in men.
Part of what makes it so frustrating is that there is no single blood test or scan that confirms it. Diagnosis relies on criteria that assess how widespread the pain is, how long it has been present and how severe the accompanying symptoms are, after other explanations have been ruled out by a qualified practitioner.
The leading explanation among researchers is central sensitisation. In simple terms, the nervous system appears to amplify pain signals, so ordinary sensations register as painful. Brain imaging studies have reported differences in activity across regions involved in processing pain, which has pushed researchers to look at interventions that might influence brain function rather than just muscles or joints.
What The Research Has Explored
One of the earlier studies came out of Turkey in 2004, when Yildiz and colleagues ran a randomised trial with a small group of participants. The hyperbaric group received sessions at 2.4 ATA breathing 100 percent oxygen for 90 minutes, fifteen times over three weeks, and researchers recorded reductions in tender point counts and reported pain scores.
A larger and more widely cited study was published in PLoS ONE in 2015 by Efrati and colleagues in Israel. Forty eight women completed 40 sessions at 2 ATA, five days a week over two months. The researchers reported improvements on symptom questionnaires and, notably, changes on brain SPECT imaging that they linked to those reported improvements.
The limitations are worth knowing. Sample sizes were small, participants were almost entirely women, blinding is genuinely difficult in this kind of study and follow up periods were short. Reviews of hyperbaric oxygen therapy and fibromyalgia have generally concluded that findings are encouraging but that larger, better controlled trials are still needed.
The Thinking Behind The Findings
Under pressure, considerably more oxygen dissolves directly into blood plasma rather than travelling attached to haemoglobin. That dissolved oxygen can reach tissue beds that red blood cells struggle to service well, which is the basic principle behind hyperbaric medicine as it is practised in hospital settings.
Applied to fibromyalgia, researchers have proposed that this increased oxygen availability may influence activity in the brain regions that imaging suggests behave differently in people with the condition. The idea draws on neuroplasticity, meaning the brain’s capacity to reorganise how it processes signals when the metabolic conditions shift.
It is important to keep this in proportion. These remain working hypotheses rather than settled science. Much of the outcome data rests on subjective questionnaires, and the studies exploring oxygen therapy for fibromyalgia symptoms have not yet been replicated at the scale that would satisfy most clinical guideline committees.
Why Study Protocols Matter So Much
The trials described above were conducted in clinical hyperbaric facilities using hard chambers pressurised to between 2 and 2.4 ATA, with participants breathing 100 percent oxygen under medical supervision. That combination of pressure, oxygen concentration and session count is the actual protocol that produced the reported results.
Milder pressurised environments operate differently. They run at lower pressures with concentrated oxygen usually delivered through a mask, which means the oxygen dose reaching the bloodstream is not the same. Research that studied hyperbaric environments in relation to fibromyalgia at clinical pressures cannot simply be assumed to apply to a different setup.
That is not a reason to dismiss anything, it is a reason to ask precise questions. If you are considering any pressurised oxygen environment, ask what pressure the equipment operates at, how oxygen is delivered, what screening happens beforehand and how the operators were trained. Discussing your own situation with your treating practitioner remains the sensible first step.
In Conclusion
Published research has explored hyperbaric oxygen at clinical pressures in small groups of people with fibromyalgia, with several studies reporting improvements in symptom scores and changes on brain imaging. The evidence base is early stage, the protocols studied were specific and the results should be read against the exact conditions of each trial rather than generalised.
If you are curious about how a pressurised oxygen environment actually works in practice, our team is happy to walk you through the equipment, the pressure range and what a session involves. Book a free consultation at one of our sites or request a quote if you are exploring a chamber for your home or business, and we will help you work out the appropriate next step.